Incidence of Severe Rotavirus Diarrhea in New Delhi, India, and G and P Types of the Infecting Rotavirus Strains
1Center for Diarrheal Disease and Nutrition Research, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India; 2Viral Gastroenteritis Division, Centers for Disease Control and Prevention, Atlanta, Georgia
A total of 62,475 children <5 years old from a defined population of
500,000 children and adults from slums in New Delhi, India, were assessed for 1 year by means of passive surveillance, to identify children who were hospitalized for diarrhea. The incidence of severe rotavirus diarrhea was estimated, and the G and P types of the infecting rotavirus strains were determined and were correlated with the clinical severity of diarrhea. Of 584 children who were hospitalized with diarrhea, 137 (23.5%) had rotavirus detected in stool specimens (incidence of rotavirus diarrhea–associated hospitalizations, 337 hospitalizations/100,000 children <5 years of age). Most cases of diarrhea (98%) occurred during the first 2 years of life, peaking at 9–11 months of age. Rotavirus‐associated diarrhea occurred year‐round but was predominant in winter. Among the strains that could be G‐typed, G1 was the most common serotype, followed by G9 and G2; 10% of cases of diarrhea were due to mixed G‐type infections. Common strains identified in the present surveillance study were P[8]G1, P[4]G2, P[8]G9, P[6]G1, P[6]G9, and P[6]G3. Children infected with G1 strains had a greater risk of developing more‐severe cases of diarrhea than did children infected with other rotavirus strains (odds ratio, 2.95; 95% confidence interval, 1.3–6.67).
Cited by
Online publication date: 1-Jun-2009.
CrossRef
Online publication date: 1-Apr-2009.
CrossRef
Online publication date: 1-Sep-2008.
CrossRef
Online publication date: 1-May-2008.
CrossRef
Online publication date: 1-Jan-2007.
Online publication date: 1-Sep-2006.
Online publication date: 1-Aug-2006.
Online publication date: 1-Sep-2005.
-
Financial support: Department of Vaccines and Biologicals, World Health Organization; Children’s Vaccine Program at the Program for Appropriate Technology in Health.
Potential conflicts of interest: none reported.
-
Members of the study group are listed at the end of the text.





